Evaluation of the VersaTREK System Compared to the Bactec MGIT 960 System for First-Line Drug Susceptibility Testing of Mycobacterium tuberculosis

被引:16
|
作者
Espasa, M. [1 ,2 ]
Salvado, M. [1 ,3 ]
Vicente, E. [1 ,3 ]
Tudo, G.
Alcaide, F. [6 ,9 ]
Coll, P. [4 ,5 ,7 ]
Martin-Casabona, N. [8 ]
Torra, M. [1 ,2 ]
Fontanals, D. [1 ,2 ]
Gonzalez-Martin, J.
机构
[1] Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain
[2] Corp Sanitaria Parc Tauli, UDIAT CD, Lab Microbiol, Sabadell, Spain
[3] Lab Referencia Catalunya, Lab Microbiol, Barcelona, Spain
[4] Univ Barcelona, Dept Anat Patol Farmacol & Microbiol, Hosp Clin Barcelona, Serv Microbiol CDB, Barcelona, Spain
[5] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain
[6] Univ Barcelona, Dept Patol & Terapeut Expt, Barcelona, Spain
[7] Hosp Univ Santa Creu & Sant Pau, Serv Microbiol, Barcelona, Spain
[8] Hosp Univ Vall Hebron, Serv Microbiol, Barcelona, Spain
[9] Hosp Univ Bellvitge, Serv Microbiol, Lhospitalet De Llobregat, Spain
关键词
ANTITUBERCULOUS DRUGS; RADIOMETRIC METHOD; ESP; PYRAZINAMIDE; COMPLEX;
D O I
10.1128/JCM.06432-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The aim of this study was to evaluate the reliability of the VersaTREK system for Mycobacterium tuberculosis drug susceptibility testing compared with results obtained with the Bactec MGIT 960 system. A total of 67 strains were evaluated. Overall agreement was at 98.5%. Kappa indexes were 1.0 for isoniazid, rifampin, and ethambutol, 0.937 for pyrazinamide, and 0.907 for streptomycin. The VersaTREK system is validated for M. tuberculosis drug susceptibility testing.
引用
收藏
页码:488 / 491
页数:4
相关论文
共 50 条
  • [1] Evaluation of BACTEC MGIT 960 System for Testing Susceptibility of Mycobacterium tuberculosis to First-Line Drugs in China
    Zhao, Ping
    Fang, Fang
    Yu, Qin
    Guo, Jiao
    Zhang, Jian-hua
    Qu, Jifu
    Liu, Yingjie
    [J]. PLOS ONE, 2014, 9 (09):
  • [2] Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs:: a multicenter study
    Kontos, F
    Maniati, M
    Costopoulos, C
    Gitti, Z
    Nicolaou, S
    Petinaki, E
    Anagnostou, S
    Tselentis, I
    Maniatis, AN
    [J]. JOURNAL OF MICROBIOLOGICAL METHODS, 2004, 56 (02) : 291 - 294
  • [3] Multicenter Evaluation of Bactec MGIT 960 System for Second-Line Drug Susceptibility Testing of Mycobacterium tuberculosis Complex
    Lin, S. -Y. Grace
    Desmond, Edward
    Bonato, Donald
    Gross, Wendy
    Siddiqi, Salman
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (11) : 3630 - 3634
  • [4] Validation of bedaquiline drug-susceptibility testing by BACTEC MGIT 960 system for Mycobacterium tuberculosis
    Sivaramakrishnan, Gomathi
    Subramanyam, Balaji
    Kumar, Michel Prem
    Golla, Radhika
    Tripathy, Srikanth Prasad
    Mondal, Rajesh
    [J]. INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2019, 8 (04) : 329 - 332
  • [5] Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide with the nonradiometric BACTEC MGIT 960 system
    Pfyffer, GE
    Palicova, F
    Rüsch-Gerdes, S
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (05) : 1670 - 1674
  • [6] Evaluation of BACTEC MGIT 960 system for the second-line drugs susceptibility testing of Mycobacterium tuberculosis in China
    Zhao, Li-li
    Xia, Qiang
    Lin, Nan
    Liu, Binbin
    Zhao, Xiu-qin
    Liu, Zhiguang
    Wan, Kang-lin
    [J]. JOURNAL OF MICROBIOLOGICAL METHODS, 2012, 91 (01) : 212 - 214
  • [7] Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs:: Comparisons of the MGIT 960 and BACTEC 460 systems
    Huang, TS
    Tu, HZ
    Lee, SSJ
    Huang, WK
    Liu, YC
    [J]. ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2002, 32 (02): : 142 - 147
  • [8] Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System
    Rodrigues, C.
    Jani, J.
    Shenai, S.
    Thakkar, P.
    Siddiqi, S.
    Mehta, A.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2008, 12 (12) : 1449 - 1455
  • [9] Evaluation of BACTEC mycobacteria growth indicator tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis
    Ardito, F
    Posteraro, B
    Sanguinetti, M
    Zanetti, S
    Fadda, G
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (12) : 4440 - 4444
  • [10] Direct Susceptibility Testing of Mycobacterium tuberculosis for Pyrazinamide by Use of the Bactec MGIT 960 System
    Demers, Anne-Marie
    Venter, Amour
    Friedrich, Sven O.
    Rojas-Ponce, Gabriel
    Mapamba, Daniel
    Jugheli, Levan
    Sasamalo, Mohammed
    Almeida, Deepak
    Dorasamy, Afton
    Jentsch, Ute
    Gibson, Mara
    Everitt, Daniel
    Eisenach, Kathleen D.
    Diacon, Andreas H.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2016, 54 (05) : 1276 - 1281